Disclosed are peptides having SEQ ID NOs: 1 to 24 that induce superoxide generation by human monocytes or neutrophils; that induce an intracellular calcium increase by human peripheral blood monocytes or neutrophils; binds to formyl peptide receptor or formyl peptide receptor-like 1; that induce chemotactic migration of human monocytes or neutrophils in vitro; that induce degranulation in formyl peptide receptor expressing cells or formyl peptide receptor-like 1 expressing cells; that stimulate extracellular signal regulated protein kinase phosphorylation via activation of formyl peptide receptor or formyl peptide receptor-like 1; or that stimulate Akt phosphorylation via activation of formyl peptide receptor or formyl peptide receptor-like 1.

 
Web www.patentalert.com

< Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith

< Treatment of eclampsia and preeclampsia

> Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21

> Controlled nucleic acid delivery systems

~ 00254